glp-1 agonist prediabetes Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action Trends in the Development of

It would be interesting to understand what actually maintains that state

Lixisenatide in participants with type 2 diabetes and acute coronary syndrome

Glucagon-like peptide-1 (GLP-1) drugs help people lose weight by making them feel fuller with less food and by signaling the brain that the stomach contains food, reducing their appetite and cravings

Preclinical studies in animal models have demonstrated that GLP-1 receptor activation may reduce amyloid-beta accumulation, decrease tau phosphorylation, and protect neurons from oxidative damage

10 Additionally, not all OSA patients are obese and therefore wouldnt benefit from GLP-1s

It should be used with a reduced calorie diet and increased physical activity